-
1
-
-
0021263352
-
Macular edema. A complication of diabetic retinopathy
-
6379946
-
Ferris FL 3rd, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol. 1984;28 Suppl:452-61.
-
(1984)
Surv Ophthalmol
, vol.28
, pp. 452-461
-
-
Ferris, F.L.1
Patz, A.2
-
2
-
-
0015541153
-
Macular edema - An overlooked complication of diabetic retinopathy
-
4738180
-
Patz A, Schatz H, Berkow JW, Gittelsohn AM, Ticho U. Macular edema - an overlooked complication of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:Op34-42.
-
(1973)
Trans Am Acad Ophthalmol Otolaryngol
, vol.77
, pp. Op34-Op42
-
-
Patz, A.1
Schatz, H.2
Berkow, J.W.3
Gittelsohn, A.M.4
Ticho, U.5
-
3
-
-
84859030420
-
Global prevalence and major risk factors of diabetic retinopathy
-
22301125 3322721
-
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556-64.
-
(2012)
Diabetes Care
, vol.35
, pp. 556-564
-
-
Yau, J.W.1
Rogers, S.L.2
Kawasaki, R.3
Lamoureux, E.L.4
Kowalski, J.W.5
Bek, T.6
Chen, S.J.7
Dekker, J.M.8
Fletcher, A.9
Grauslund, J.10
-
4
-
-
0021748399
-
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema
-
6521986
-
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91:1464-74.
-
(1984)
Ophthalmology
, vol.91
, pp. 1464-1474
-
-
Klein, R.1
Klein, B.E.2
Moss, S.E.3
Davis, M.D.4
DeMets, D.L.5
-
5
-
-
7244240730
-
Epidemiology of diabetic retinopathy and macular oedema: A systematic review
-
Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond). 2004;18:963-83.
-
(2004)
Eye (Lond)
, vol.18
, pp. 963-983
-
-
Williams, R.1
Airey, M.2
Baxter, H.3
Forrester, J.4
Kennedy-Martin, T.5
Girach, A.6
-
6
-
-
79251606719
-
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
-
20980427 2963502
-
Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, Mitchell P, Sharp D, Wolf-Schnurrbusch UE, Gekkieva M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care. 2010;33:2399-405.
-
(2010)
Diabetes Care
, vol.33
, pp. 2399-2405
-
-
Massin, P.1
Bandello, F.2
Garweg, J.G.3
Hansen, L.L.4
Harding, S.P.5
Larsen, M.6
Mitchell, P.7
Sharp, D.8
Wolf-Schnurrbusch, U.E.9
Gekkieva, M.10
-
7
-
-
84885022258
-
Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from two phase III trials: RISE and RIDE
-
23706949
-
Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology. 2013;120:2013-22.
-
(2013)
Ophthalmology
, vol.120
, pp. 2013-2022
-
-
Brown, D.M.1
Nguyen, Q.D.2
Marcus, D.M.3
Boyer, D.S.4
Patel, S.5
Feiner, L.6
Schlottmann, P.G.7
Rundle, A.C.8
Zhang, J.9
Rubio, R.G.10
-
8
-
-
84863401792
-
Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE
-
22330964
-
Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119:789-801.
-
(2012)
Ophthalmology
, vol.119
, pp. 789-801
-
-
Nguyen, Q.D.1
Brown, D.M.2
Marcus, D.M.3
Boyer, D.S.4
Patel, S.5
Feiner, L.6
Gibson, A.7
Sy, J.8
Rundle, A.C.9
Hopkins, J.J.10
-
9
-
-
78049293726
-
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
-
20855114
-
Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2010;117:2146-51.
-
(2010)
Ophthalmology
, vol.117
, pp. 2146-2151
-
-
Nguyen, Q.D.1
Shah, S.M.2
Khwaja, A.A.3
Channa, R.4
Hatef, E.5
Do, D.V.6
Boyer, D.7
Heier, J.S.8
Abraham, P.9
Thach, A.B.10
-
10
-
-
84865593623
-
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: Report 3
-
22491395
-
Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, Peto T, Egan C, Bunce C, Leslie RD, Hykin PG. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol. 2012;130:972-9.
-
(2012)
Arch Ophthalmol
, vol.130
, pp. 972-979
-
-
Rajendram, R.1
Fraser-Bell, S.2
Kaines, A.3
Michaelides, M.4
Hamilton, R.D.5
Esposti, S.D.6
Peto, T.7
Egan, C.8
Bunce, C.9
Leslie, R.D.10
Hykin, P.G.11
-
11
-
-
84923683412
-
Automated retinal image analysis for diabetic retinopathy in telemedicine
-
25697773
-
Sim DA, Keane PA, Tufail A, Egan CA, Aiello LP, Silva PS. Automated retinal image analysis for diabetic retinopathy in telemedicine. Curr Diab Rep. 2015;15:14.
-
(2015)
Curr Diab Rep
, vol.15
, pp. 14
-
-
Sim, D.A.1
Keane, P.A.2
Tufail, A.3
Egan, C.A.4
Aiello, L.P.5
Silva, P.S.6
-
12
-
-
79251481714
-
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant
-
20702826
-
Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2011;52:80-6.
-
(2011)
Invest Ophthalmol Vis Sci
, vol.52
, pp. 80-86
-
-
Chang-Lin, J.E.1
Attar, M.2
Acheampong, A.A.3
Robinson, M.R.4
Whitcup, S.M.5
Kuppermann, B.D.6
Welty, D.7
-
13
-
-
84908118639
-
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
-
24907062
-
Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM, Ozurdex MSG. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121:1904-14.
-
(2014)
Ophthalmology
, vol.121
, pp. 1904-1914
-
-
Boyer, D.S.1
Yoon, Y.H.2
Belfort, R.3
Bandello, F.4
Maturi, R.K.5
Augustin, A.J.6
Li, X.Y.7
Cui, H.8
Hashad, Y.9
Whitcup, S.M.10
Ozurdex, M.S.G.11
-
14
-
-
84861327424
-
Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
-
22569393 3361827
-
Sharma A, Madhusudhan RJ, Nadahalli V, Damgude SA, Sundaramoorthy SK. Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report. Indian J Ophthalmol. 2012;60:234-5.
-
(2012)
Indian J Ophthalmol
, vol.60
, pp. 234-235
-
-
Sharma, A.1
Madhusudhan, R.J.2
Nadahalli, V.3
Damgude, S.A.4
Sundaramoorthy, S.K.5
-
15
-
-
85047776758
-
Longterm treatment of diabetic macular edema with dexamethasone im plant after unsatisfactory response to anti- VEGF therapy
-
Garweg JG, Zandi S. Longterm treatment of diabetic macular edema with dexamethasone Im plant after unsatisfactory response to anti- VEGF therapy. Investig Ophthalmol Vis Sci. 2015;56:217.
-
(2015)
Investig Ophthalmol Vis Sci
, vol.56
, pp. 217
-
-
Garweg, J.G.1
Zandi, S.2
-
16
-
-
85047726395
-
Intravitreal dexamethasone implant in eyes with chronic refractory diabetic macular oedema
-
Giralt J, Alforja S, Keller J, Latasiewicz M, Fontecilla C, Civera AA. Intravitreal dexamethasone implant in eyes with chronic refractory diabetic macular oedema. Investig Ophthalmol Vis Sci. 2014;55:1782.
-
(2014)
Investig Ophthalmol Vis Sci
, vol.55
, pp. 1782
-
-
Giralt, J.1
Alforja, S.2
Keller, J.3
Latasiewicz, M.4
Fontecilla, C.5
Civera, A.A.6
-
17
-
-
85047737045
-
Reduced efficacy of intravitreal dexamethasone implant in diabetic macular edema with subfoveal cystoid spaces
-
Sun HJ, Lee SJ. Reduced efficacy of intravitreal dexamethasone implant in diabetic macular edema with subfoveal cystoid spaces. Investig Ophthalmol Vis Sci. 2016;57:3249.
-
(2016)
Investig Ophthalmol Vis Sci
, vol.57
, pp. 3249
-
-
Sun, H.J.1
Lee, S.J.2
-
18
-
-
79955558683
-
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients
-
21487341
-
Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, Liu CC, Lou J, Whitcup SM, Ozurdex CSG. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011;31:915-23.
-
(2011)
Retina
, vol.31
, pp. 915-923
-
-
Boyer, D.S.1
Faber, D.2
Gupta, S.3
Patel, S.S.4
Tabandeh, H.5
Li, X.Y.6
Liu, C.C.7
Lou, J.8
Whitcup, S.M.9
Ozurdex, C.S.G.10
-
19
-
-
84945912720
-
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
-
26519345
-
Augustin AJ, Kuppermann BD, Lanzetta P, Loewenstein A, Li X-Y, Cui H, Hashad Y, Whitcup SM. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. BMC Ophthalmol. 2015;15. PMID: 26519345. https://doi.org/10.1186/s12886-015-0148-2.
-
(2015)
BMC Ophthalmol
, pp. 15
-
-
Augustin, A.J.1
Kuppermann, B.D.2
Lanzetta, P.3
Loewenstein, A.4
Li, X.-Y.5
Cui, H.6
Hashad, Y.7
Whitcup, S.M.8
-
20
-
-
85047740894
-
Intravitreal dexamethasone implant (Ozurdex) as primary treatment for diabetic macular edema
-
Cui QN, Stewart JM. Intravitreal dexamethasone implant (Ozurdex) as primary treatment for diabetic macular edema. Investig Ophthalmol Vis Sci. 2014;55:1780.
-
(2014)
Investig Ophthalmol Vis Sci
, vol.55
, pp. 1780
-
-
Cui, Q.N.1
Stewart, J.M.2
-
21
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
The PG 19621072 2707599
-
Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
-
(2009)
PLoS Med
, vol.6
, pp. e1000097
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
22
-
-
84974793861
-
Grading quality of evidence and strength of recommendations
-
15205295
-
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
-
(2004)
BMJ
, vol.328
, pp. 1490
-
-
Atkins, D.1
Best, D.2
Briss, P.A.3
Eccles, M.4
Falck-Ytter, Y.5
Flottorp, S.6
Guyatt, G.H.7
Harbour, R.T.8
Haugh, M.C.9
Henry, D.10
-
23
-
-
84922192847
-
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: The BEVORDEX study
-
25155371
-
Gillies MC, Lim LL, Campain A, Quin GJ, Salem W, Li J, Goodwin S, Aroney C, McAllister IL, Fraser-Bell S. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology. 2014;121:2473-81.
-
(2014)
Ophthalmology
, vol.121
, pp. 2473-2481
-
-
Gillies, M.C.1
Lim, L.L.2
Campain, A.3
Quin, G.J.4
Salem, W.5
Li, J.6
Goodwin, S.7
Aroney, C.8
McAllister, I.L.9
Fraser-Bell, S.10
-
24
-
-
84973884837
-
Prospective randomized subject-masked study of intravitreal bevacizumab monotherapy versus dexamethasone implant monotherapy in the treatment of persistent diabetic macular edema
-
27124881
-
Shah SU, Harless A, Bleau L, Maturi RK. Prospective randomized subject-masked study of intravitreal bevacizumab monotherapy versus dexamethasone implant monotherapy in the treatment of persistent diabetic macular edema. Retina. 2016;36:1986-96.
-
(2016)
Retina
, vol.36
, pp. 1986-1996
-
-
Shah, S.U.1
Harless, A.2
Bleau, L.3
Maturi, R.K.4
-
25
-
-
84992386850
-
Vision-related quality of life outcomes in the BEVORDEX study: A clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema
-
27768792
-
Aroney C, Fraser-Bell S, Lamoureux EL, Gillies MC, Lim LL, Fenwick EK. Vision-related quality of life outcomes in the BEVORDEX study: a clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci. 2016;57:5541-6.
-
(2016)
Invest Ophthalmol Vis Sci
, vol.57
, pp. 5541-5546
-
-
Aroney, C.1
Fraser-Bell, S.2
Lamoureux, E.L.3
Gillies, M.C.4
Lim, L.L.5
Fenwick, E.K.6
-
28
-
-
84975698767
-
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: Two-year results from a comparative effectiveness randomized clinical trial
-
26935357 4877252
-
Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology. 2016;123:1351-9.
-
(2016)
Ophthalmology
, vol.123
, pp. 1351-1359
-
-
Wells, J.A.1
Glassman, A.R.2
Ayala, A.R.3
Jampol, L.M.4
Bressler, N.M.5
Bressler, S.B.6
Brucker, A.J.7
Ferris, F.L.8
Hampton, G.R.9
Jhaveri, C.10
-
29
-
-
79960190061
-
Inflammation in diabetic retinopathy
-
21635964 3433044
-
Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30:343-58.
-
(2011)
Prog Retin Eye Res
, vol.30
, pp. 343-358
-
-
Tang, J.1
Kern, T.S.2
-
30
-
-
42449135678
-
Immunological mechanisms in the pathogenesis of diabetic retinopathy
-
18340447
-
Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30:65-84.
-
(2008)
Semin Immunopathol
, vol.30
, pp. 65-84
-
-
Adamis, A.P.1
Berman, A.J.2
-
31
-
-
84871311849
-
Cytokine concentration in aqueous humor of eyes with diabetic macular edema
-
22617833
-
Jonas JB, Jonas RA, Neumaier M, Findeisen P. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina. 2012;32:2150-7.
-
(2012)
Retina
, vol.32
, pp. 2150-2157
-
-
Jonas, J.B.1
Jonas, R.A.2
Neumaier, M.3
Findeisen, P.4
-
32
-
-
2442547705
-
Corticosteroids in posterior segment disease: An update on new delivery systems and new indications
-
15118508
-
Ciulla TA, Walker JD, Fong DS, Criswell MH. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Curr Opin Ophthalmol. 2004;15:211-20.
-
(2004)
Curr Opin Ophthalmol
, vol.15
, pp. 211-220
-
-
Ciulla, T.A.1
Walker, J.D.2
Fong, D.S.3
Criswell, M.H.4
-
33
-
-
84925423332
-
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
-
25692915
-
Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372:1193-203.
-
(2015)
N Engl J Med
, vol.372
, pp. 1193-1203
-
-
Wells, J.A.1
Glassman, A.R.2
Ayala, A.R.3
Jampol, L.M.4
Aiello, L.P.5
Antoszyk, A.N.6
Arnold-Bush, B.7
Baker, C.W.8
Bressler, N.M.9
Browning, D.J.10
-
34
-
-
84937709345
-
Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: The CHROME study
-
26203215 4506028
-
Lam WC, Albiani DA, Yoganathan P, Chen JC, Kherani A, Maberley DA, Oliver A, Rabinovitch T, Sheidow TG, Tourville E, et al. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clin Ophthalmol. 2015;9:1255-68.
-
(2015)
Clin Ophthalmol
, vol.9
, pp. 1255-1268
-
-
Lam, W.C.1
Albiani, D.A.2
Yoganathan, P.3
Chen, J.C.4
Kherani, A.5
Maberley, D.A.6
Oliver, A.7
Rabinovitch, T.8
Sheidow, T.G.9
Tourville, E.10
-
35
-
-
84938810401
-
A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-vegf injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy
-
25829346
-
Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW. A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-vegf injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy. Retina. 2015;35:1604-14.
-
(2015)
Retina
, vol.35
, pp. 1604-1614
-
-
Maturi, R.K.1
Bleau, L.2
Saunders, J.3
Mubasher, M.4
Stewart, M.W.5
-
36
-
-
85021119472
-
Anti-vascular endothelial growth factor for diabetic macular oedema
-
25342124
-
Virgili G, Parravano M, Menchini F, Evans JR. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev 2014:Cd007419. PMID:25342124. https://doi.org/10.1002/14651858.CD007419.pub4.
-
(2014)
Cochrane Database Syst Rev
, pp. Cd007419
-
-
Virgili, G.1
Parravano, M.2
Menchini, F.3
Evans, J.R.4
-
37
-
-
84958568980
-
Systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: A systematic review and meta-analysis
-
26513684
-
Avery RL, Gordon GM. Systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis. JAMA Ophthalmol. 2016;134:21-9.
-
(2016)
JAMA Ophthalmol
, vol.134
, pp. 21-29
-
-
Avery, R.L.1
Gordon, G.M.2
-
38
-
-
70350575734
-
Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies
-
19712924
-
Csaky K, Do DV. Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies. Am J Ophthalmol. 2009;148:647-56.
-
(2009)
Am J Ophthalmol
, vol.148
, pp. 647-656
-
-
Csaky, K.1
Do, D.V.2
-
39
-
-
80052445162
-
Economic considerations of macular edema therapies
-
21507488 3483086
-
Smiddy WE. Economic considerations of macular edema therapies. Ophthalmology. 2011;118:1827-33.
-
(2011)
Ophthalmology
, vol.118
, pp. 1827-1833
-
-
Smiddy, W.E.1
-
40
-
-
84988699023
-
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
-
27621587 5010173
-
Thomas BJ, Yonekawa Y, Wolfe JD, Hassan TS. Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema. Clin Ophthalmol. 2016;10:1679-84.
-
(2016)
Clin Ophthalmol
, vol.10
, pp. 1679-1684
-
-
Thomas, B.J.1
Yonekawa, Y.2
Wolfe, J.D.3
Hassan, T.S.4
-
41
-
-
84897576584
-
Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant
-
23975006
-
Lazic R, Lukic M, Boras I, Draca N, Vlasic M, Gabric N, Tomic Z. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Retina. 2014;34:719-24.
-
(2014)
Retina
, vol.34
, pp. 719-724
-
-
Lazic, R.1
Lukic, M.2
Boras, I.3
Draca, N.4
Vlasic, M.5
Gabric, N.6
Tomic, Z.7
-
42
-
-
85018525253
-
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
-
28423385
-
Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, Jonas J, Larsen M, Tadayoni R, Loewenstein A. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237:185-222.
-
(2017)
Ophthalmologica
, vol.237
, pp. 185-222
-
-
Schmidt-Erfurth, U.1
Garcia-Arumi, J.2
Bandello, F.3
Berg, K.4
Chakravarthy, U.5
Gerendas, B.S.6
Jonas, J.7
Larsen, M.8
Tadayoni, R.9
Loewenstein, A.10
-
43
-
-
84925437893
-
Anti-vascular endothelial growth factor for diabetic macular oedema: A network meta-analysis
-
28639415
-
Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database Syst Rev. 2017;6:CD007419.
-
(2017)
Cochrane Database Syst Rev
, vol.6
, pp. CD007419
-
-
Virgili, G.1
Parravano, M.2
Evans, J.R.3
Gordon, I.4
Lucenteforte, E.5
|